Related Experiment Video
Updated: Aug 9, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
CRAC channel is inhibited by neomycin in a Ptdlns(4,5)P2-independent manner
Kun Huang1, Xuemei Wang, Yanjun Liu
1Department of Ultrasound, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Abstract:
Depletion of intracellular Ca(2+) stores evokes store-operated Ca(2+) entry through the Ca(2+) release-activated Ca(2+) (CRAC) channels. In this study, we found that the store-operated Ca(2+) entry was inhibited by neomycin, an aminoglycoside that strongly binds phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Patch clamp recordings revealed that neomycin blocked the CRAC currents reconstituted by co-expression of Orai1 and Stim1 in HEK293 cells. Using a rapamycin-inducible PtdIns(4,5)P2-specific phosphatase (Inp54p) system to manipulate the PtdIns(4,5)P2 in the plasma membrane, we found that the CRAC current was not altered by PtdIns(4,5)P2 depletion. This result suggests that PtdIns(4,5)P2 is not required for CRAC channel activity, and thereby, neomycin inhibits CRAC channels in a manner that is independent of neomycin-PtdIns(4,5)P2 binding.
Insights
Neomycin inhibits store-operated calcium entry via CRAC channels. This inhibition is independent of neomycin
Area of Science:
- Cellular biology
- Molecular pharmacology
- Ion channel physiology
Background:
- Store-operated calcium entry (SOCE) is crucial for cellular calcium homeostasis.
- Calcium release-activated calcium (CRAC) channels mediate SOCE.
- Neomycin, an aminoglycoside, is known to bind phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2).
Purpose of the Study:
- To investigate the mechanism by which neomycin inhibits CRAC channel activity.
- To determine the role of PtdIns(4,5)P2 in neomycin-mediated inhibition of CRAC channels.
Main Methods:
- Patch clamp electrophysiology to record CRAC currents.
- Co-expression of Orai1 and Stim1 in HEK293 cells to reconstitute CRAC channels.
- Utilizing a rapamycin-inducible PtdIns(4,5)P2-specific phosphatase (Inp54p) system to manipulate plasma membrane PtdIns(4,5)P2 levels.
Main Results:
- Neomycin inhibited CRAC currents reconstituted by Orai1 and Stim1.
- Depletion of PtdIns(4,5)P2 using the Inp54p system did not alter CRAC channel activity.
- Neomycin's inhibition of CRAC channels was independent of its binding to PtdIns(4,5)P2.
Conclusions:
- Phosphatidylinositol 4,5-bisphosphate is not required for CRAC channel function.
- Neomycin inhibits CRAC channels through a mechanism independent of PtdIns(4,5)P2 binding.

